Acasti Pharma Inc. (NASDAQ:ACST – Get Free Report) saw a large increase in short interest in April. As of April 15th, there was short interest totalling 3,800 shares, an increase of 171.4% from the March 31st total of 1,400 shares. Approximately 0.1% of the company’s shares are sold short. Based on an average trading volume […]
Shares of Acasti Pharma Inc. (NASDAQ:ACST – Get Free Report) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $2.65 and traded as high as $3.41. Acasti Pharma shares last traded at $3.38, with a volume of 34,601 shares traded. Wall Street Analysts Forecast Growth […]
Acasti Pharma Inc. (NASDAQ:ACST – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $2.65 and traded as high as $3.41. Acasti Pharma shares last traded at $3.38, with a volume of 34,601 shares. Analyst Ratings Changes Separately, Craig Hallum […]
This Viewpoint discusses the drawbacks of using glucagon-like peptide 1 (GLP-1) agonists to treat obesity and presents an alternative approach of initial, stage